Hepatotoxicity in drug development: clinical control, early signals and pre-clinical prediction

被引：0
|
作者：
Steinmann, G. G. [1 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2007年 / 101卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PMS-3
引用
收藏
页码：365 / 365
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetic Drug Interactions of Piperine: A Review of Pre-clinical and Clinical Studies
    Najar, Imtiyaz Ahmed
    Pamu, Sagar
    Paul, Anushka
    Arora, Poonam
    Kaur, Gaganjit
    Kumar, Manish
    CURRENT DRUG METABOLISM, 2024,
  • [32] The symposium that never occurred: pre-clinical and clinical development of sibenadet
    Rennard, SI
    RESPIRATORY MEDICINE, 2003, 97 : S1 - S2
  • [33] Fulvestrant: A review of its development, pre-clinical and clinical data
    Wardley, AM
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (04) : 305 - 309
  • [34] Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations
    Abduelkarem, Abduelmula R.
    Anbar, Hanan S.
    Zaraei, Seyed-Omar
    Alfar, Aya A.
    Al-Zoubi, Omayma S.
    Abdelkarem, Eveen G.
    El-Gamal, Mohammed I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 188
  • [35] Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
    Qin, Yi
    Ashrafizadeh, Milad
    Mongiardini, Vera
    Grimaldi, Benedetto
    Crea, Francesco
    Rietdorf, Katja
    Gyorffy, Balazs
    Klionsky, Daniel J.
    Ren, Jun
    Zhang, Wei
    Zhang, Xianbin
    CANCER LETTERS, 2023, 570
  • [36] Drug-induced torsade de pointes: pre-clinical and clinical studies for the prediction of a potential proarrhythmic adverse drug reaction
    Jaillon, P
    Dupuis, B
    Dahan, R
    Bottineau, G
    Caron, J
    Cazor, JL
    Chauvenet, M
    Clement, JP
    Escande, D
    Faisandier, Y
    FunckBrentano, C
    Kolsky, H
    Koen, R
    Lacroix, D
    Leenhardt, A
    Lehner, JP
    Prost, JF
    Swynghedauw, B
    Vassort, G
    Weissenburger, J
    Wohlhuter, C
    THERAPIE, 1997, 52 (04): : 271 - 280
  • [37] Pre-Clinical Drug Development Studies in Fragile-X: The NIH Perspective
    Beckel-Mitchener, A.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (07) : 701 - 701
  • [38] Reducing attrition in drug development: Smart loading pre-clinical safety assessment
    Kavanagh, Stefan
    Mellor, Howard
    Pollard, Christopher
    Robinson, Sally
    Platz, Stefan
    Roberts, Ruth
    TOXICOLOGY LETTERS, 2014, 229 : S167 - S167
  • [39] Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
    Jaimes-Aguirre, Laura
    Vianey Gibbens-Bandala, Brenda
    Morales-Avila, Enrique
    Eli Ocampo-Garcia, Blanca
    Seyedeh-Fatemeh, Mirshojaei
    Amirhosein, Ahmadi
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (19) : 2886 - 2903
  • [40] PRE-CLINICAL DEVELOPMENT OF CGM-CKM
    Tamir, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A8 - A9
12345